Patient-Focused Drug Development Methods for Benefit-Risk Assessments: A Case Study Using a Discrete Choice Experiment for Antiepileptic Drugs. (2019)
Attributed to:
Renewal of the Network of Hubs for Trials Methodology Research.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cpt.1231
PubMed Identifier: 30204252
Publication URI: http://europepmc.org/abstract/MED/30204252
Type: Journal Article/Review
Volume: 105
Parent Publication: Clinical pharmacology and therapeutics
Issue: 3
ISSN: 0009-9236